JP2024519993A5 - - Google Patents

Info

Publication number
JP2024519993A5
JP2024519993A5 JP2023572661A JP2023572661A JP2024519993A5 JP 2024519993 A5 JP2024519993 A5 JP 2024519993A5 JP 2023572661 A JP2023572661 A JP 2023572661A JP 2023572661 A JP2023572661 A JP 2023572661A JP 2024519993 A5 JP2024519993 A5 JP 2024519993A5
Authority
JP
Japan
Prior art keywords
groups
group
homologous
heterocyclyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023572661A
Other languages
English (en)
Japanese (ja)
Other versions
JP7881616B2 (ja
JP2024519993A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/095441 external-priority patent/WO2022247920A1/zh
Publication of JP2024519993A publication Critical patent/JP2024519993A/ja
Publication of JP2024519993A5 publication Critical patent/JP2024519993A5/ja
Application granted granted Critical
Publication of JP7881616B2 publication Critical patent/JP7881616B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023572661A 2021-05-27 2022-05-27 キノリンアミン系化合物、その調製方法及びその医薬的応用 Active JP7881616B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202110606803 2021-05-27
CN202110606803.1 2021-05-27
CN202110976020.2 2021-08-24
CN202110976020 2021-08-24
PCT/CN2022/095441 WO2022247920A1 (zh) 2021-05-27 2022-05-27 喹啉胺类化合物、其制备方法及其在医药上的应用

Publications (3)

Publication Number Publication Date
JP2024519993A JP2024519993A (ja) 2024-05-21
JP2024519993A5 true JP2024519993A5 (cg-RX-API-DMAC7.html) 2025-05-16
JP7881616B2 JP7881616B2 (ja) 2026-06-29

Family

ID=84228425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572661A Active JP7881616B2 (ja) 2021-05-27 2022-05-27 キノリンアミン系化合物、その調製方法及びその医薬的応用

Country Status (11)

Country Link
US (1) US20240327388A1 (cg-RX-API-DMAC7.html)
EP (1) EP4349831B1 (cg-RX-API-DMAC7.html)
JP (1) JP7881616B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240014059A (cg-RX-API-DMAC7.html)
CN (1) CN117222639B (cg-RX-API-DMAC7.html)
AU (1) AU2022283404A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023024741A2 (cg-RX-API-DMAC7.html)
CA (1) CA3219657A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023013972A (cg-RX-API-DMAC7.html)
TW (1) TW202313592A (cg-RX-API-DMAC7.html)
WO (1) WO2022247920A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202436295A (zh) * 2022-11-25 2024-09-16 大陸商江蘇恒瑞醫藥股份有限公司 喹啉胺類化合物的可藥用鹽、晶型及其製備方法
TW202436296A (zh) * 2022-11-25 2024-09-16 大陸商江蘇恒瑞醫藥股份有限公司 喹啉胺類化合物晶型及其製備方法
CN116854634B (zh) * 2023-06-27 2025-12-09 广东药科大学 一种选择性ces2抑制剂、其制备方法及其作为药物的用途
IL326865A (en) * 2023-08-30 2026-04-01 Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd Compound for regulating activity of microrna-124
WO2025201294A1 (zh) * 2024-03-26 2025-10-02 深圳信立泰药业股份有限公司 一种吲哚类化合物及其制备方法与miR上调应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5648599A (en) * 1998-09-11 2000-04-03 Kyorin Pharmaceutical Co. Ltd. Phosphonic ester derivatives and process for producing the same
CN102625804B (zh) 2009-06-12 2015-04-08 Abivax公司 用于治疗aids的化合物
JP2011026251A (ja) * 2009-07-27 2011-02-10 Kowa Co 2−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤
WO2012037351A1 (en) 2010-09-17 2012-03-22 Glaxosmithkline Llc Compounds
CN104109165A (zh) 2013-04-19 2014-10-22 四川海思科制药有限公司 4,5-二氢-吡唑并[3,4-c]吡啶-2-酮衍生物、其制备方法以及应用
CA2916623C (en) 2013-07-05 2021-09-14 Abivax Bicyclic compounds useful for treating diseases caused by retroviruses
EP2974729A1 (en) 2014-07-17 2016-01-20 Abivax Quinoline derivatives for use in the treatment of inflammatory diseases
EP3059236A1 (en) * 2015-02-23 2016-08-24 Abivax A new quinoline derivative for use in the treatment and prevention of viral infections
WO2017158201A1 (en) 2016-03-18 2017-09-21 Ratiopharm Gmbh Process for preparing quinolin-2-yl-phenylamine derivatives and their salts
EP3669873A1 (en) * 2018-12-20 2020-06-24 Abivax Quinoline derivatives for use ine the traeatment of inflammation diseases
CA3168533A1 (en) * 2020-01-24 2021-07-29 The Trustees Of Princeton University Heterocyclic compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2021523112A5 (cg-RX-API-DMAC7.html)
JP2024519188A5 (cg-RX-API-DMAC7.html)
JP2024522766A5 (cg-RX-API-DMAC7.html)
AU2020281003A1 (en) Process for preparing an anti-cancer agent, 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts
JP2020066629A5 (cg-RX-API-DMAC7.html)
JP2018519323A5 (cg-RX-API-DMAC7.html)
JP2019518766A5 (cg-RX-API-DMAC7.html)
CN110573501A (zh) Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
JP2018536705A5 (cg-RX-API-DMAC7.html)
JP2019519476A5 (cg-RX-API-DMAC7.html)
JP2018511634A5 (cg-RX-API-DMAC7.html)
JP2016514719A5 (cg-RX-API-DMAC7.html)
JP2023534528A5 (cg-RX-API-DMAC7.html)
JP2019507130A5 (cg-RX-API-DMAC7.html)
JP2002513035A (ja) Cox−2阻害薬の合成方法
JP2023164918A5 (cg-RX-API-DMAC7.html)
JP2020506899A5 (cg-RX-API-DMAC7.html)
JP2023509944A5 (cg-RX-API-DMAC7.html)
JP2020535124A5 (cg-RX-API-DMAC7.html)
SI3102573T1 (en) SUBSTITUTED TIAZOL OR OXASOL AS ANTAGONISTS OF THE RECEPTOR P2X7
WO2014168522A4 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
JP2021510692A5 (cg-RX-API-DMAC7.html)
JP2020511547A5 (cg-RX-API-DMAC7.html)
JP2023554081A5 (cg-RX-API-DMAC7.html)
JP2020503376A5 (cg-RX-API-DMAC7.html)